Yunnan Baiyao Group Co.,Ltd (SHE:000538)
China
· Delayed Price · Currency is CNY 57.47
+0.14 (0.24%)
Apr 18, 2025, 2:45 PM CST
SHE:000538 Revenue
In the year 2024, Yunnan Baiyao Group Co.,Ltd had annual revenue of 40.03B CNY with 2.36% growth. Yunnan Baiyao Group Co.,Ltd had revenue of 10.12B in the quarter ending December 31, 2024, with 7.38% growth.
Revenue
40.03B
Revenue Growth
+2.36%
P/S Ratio
2.56
Revenue / Employee
4.32M
Employees
9,277
Market Cap
102.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40.03B | 922.01M | 2.36% |
| Dec 31, 2023 | 39.11B | 2.62B | 7.19% |
| Jan 1, 2023 | 36.49B | 114.45M | 0.31% |
| Jan 1, 2022 | 36.37B | 3.63B | 11.09% |
| Dec 31, 2020 | 32.74B | 3.08B | 10.38% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.25B |